|
|
| Model Number |
PCO20X |
| Medical Device Problem Codes |
Material Integrity Problem (2978); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Abscess (1690); Adhesion(s) (1695); Erosion (1750); Purulent Discharge (1812); Hemorrhage/Blood Loss/Bleeding (1888); Hypersensitivity/Allergic reaction (1907); Unspecified Infection (1930); Inflammation (1932); Internal Organ Perforation (1987); Pain (1994); Seroma (2069); Impaired Healing (2378); Unspecified Tissue Injury (4559)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of hernia.It was reported that after implant, the patient experienced infection, abscess, adhesions, pain, seroma, inflammation, and organ perforation.Post-operative patient treatment included revision surgeries, wound vac placement and small bowel resection.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a2 (date of birth), a3a, a4, b5, b7, d4 (expiration date, lot #, udi #), h4, h6 (patient codes, imf code, device code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced allergic reaction, bleeding, phlegmon, nonhealing surgical wound, contracted mesh, mesh erosion into small bowel, discharge of blood and pus from wound, infection, abscess, adhesions, pain, seroma, inflammation, and organ perforation.Post-operative patient treatment included incision and drainage, abdominal wound exploration, removal of foreign body, lysis of adhesions, mesh removal, revision surgeries, wound vac placement and small bowel resection.
|
| |
|
Search Alerts/Recalls
|
|
|